Status:

RECRUITING

A Study of Enterorenal Syndrome Assessed by Gastrointestinal Ultrasound Combined with Renal Artery Resistance Index

Lead Sponsor:

Zhangzhou Municipal Hospital

Conditions:

Sepsis

Urinary Tract Infections

Eligibility:

All Genders

14-85 years

Brief Summary

In this study, the patients with sepsis caused by abdominal infection were divided into survival group and death group by ultrasound examination of gastrointestinal function, superior mesenteric arter...

Detailed Description

Adult patients admitted to EICU of our hospital who met the diagnostic criteria for sepsis were included in the study. Patients with intra-abdominal sepsis were divided into survival group and death g...

Eligibility Criteria

Inclusion

  • Patients diagnosed with intra-abdominal infections
  • Patients with sepsis or septic shock

Exclusion

  • Patients with open chest or abdominal injury
  • Patients with advanced tumor
  • Patients with uremia
  • Pregnant women

Key Trial Info

Start Date :

January 19 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2025

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT06505512

Start Date

January 19 2024

End Date

March 31 2025

Last Update

February 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Qingjiang Zheng

Zhangzhou, Fujian, China, 363000